Overall rank by patents
#25,891
Across all tracked assignees
USPTO PatentsView assignee record - 10 granted patents across 10 technology areas, active 2020–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).
The verdict
Beijing holds 10 US patents across 10 technology areas, rank #25,891 of 50,000 tracked assignees.
Beijing Friendship Hospital, Capital Medical University has been granted 10 US utility patents between 2020 and 2025, placing Beijing Friendship Hospital, Capital Medical University at rank #25,891 across all assignees tracked by PlainPatent. This portfolio spans 10 distinct Cooperative Patent Classification (CPC) subclasses, averaging 12.1 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a Foreign Corporation, Beijing Friendship Hospital, Capital Medical University is one of the more focused assignees in the PatentsView dataset. By volume, Beijing sits between Be Spoon (10 patents, rank #25,887) and Bellco S.r.l. (10 patents, rank #25,895) - the closest US assignees by grant volume. The composite Innovation Score of 46.7/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2020 through 2025, with 10 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Beijing Friendship Hospital, Capital Medical University's 12.1 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 10 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Beijing Friendship Hospital, Capital Medical University against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Be Spoon
10 patents
Beaufurn, LLC
10 patents
Beelinx USA, L.L.C.
10 patents
Beijing Founder Apabi Technology Limited
10 patents
Beijing Shunzao Technology Co., Ltd.
10 patents
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
10 patents
Bell Laboratories, Inc.
10 patents
Bellco S.R.L.
10 patents
Beijing Friendship Hospital, Capital Medical University
10 patents
What this shows Beijing holds 10 patents at rank #25,891, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Beijing's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
47 Top 20% higher than 80% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2020 | 1 | 10.0% |
| 2021 | 1 | 10.0% |
| 2023 | 1 | 10.0% |
| 2024 | 5 | 50.0% |
| 2025 | 2 | 20.0% |
Top 10 of 10 technology areas
Overall rank by patents
#25,891
Across all tracked assignees
46.7 out of 100
How to use this portfolio
Beijing's 10 grants land it in the top 20% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.